| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 140 |
| 1 | OMALIZUMAB | 109 |
| 2 | MONTELUKAST SODIUM | 82 |
| 3 | PREDNISONE | 82 |
| 4 | TIOTROPIUM BROMIDE | 82 |
| 5 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 65 |
| 6 | ALBUTEROL | 49 |
| 7 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 47 |
| 8 | MEPOLIZUMAB | 46 |
| 9 | CICLESONIDE | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | 1 | 0.2000 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 2 | 0.0030 |
| 2 | ANTIBACTERIAL HAND WIPES | 1 | 0.0030 |
| 3 | BENZALKONIUM CHLORIDE 0.13% | 1 | 0.0027 |
| 4 | CICLESONIDE | 34 | 0.0025 |
| 5 | BENZALKONIUM CHLORIDE | 1 | 0.0023 |
| 6 | GLYCOPYRRONIUM | 3 | 0.0019 |
| 7 | RESLIZUMAB | 1 | 0.0015 |
| 8 | GLYCOPYRROLATE | 8 | 0.0014 |
| 9 | OMALIZUMAB | 109 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 158 |
| 1 | Anti-IgE [EPC] | 109 |
| 2 | Interleukin-5 Antagonist [EPC] | 47 |
| 3 | Proton Pump Inhibitor [EPC] | 37 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 36 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 18 |
| 7 | beta-Adrenergic Blocker [EPC] | 15 |
| 8 | Provitamin D2 Compound [EPC] | 14 |
| 9 | Benzodiazepine [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 47 | 0.0683 |
| 1 | Anti-IgE [EPC] | 109 | 0.0013 |
| 2 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 3 | Thymic Stromal Lymphopoietin Blocker [EPC] | 4 | 0.0006 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 6 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 9 | 0.0004 |
| 7 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 8 | 0.0002 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 6 | 0.0002 |